AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19046856
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (IVIP)
Trial: 8279842
Drug: Surgical adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical adjuvant chemotherapy for colorectal cancer; details on dosage and duration not available.
Trial: 15797167
Drug: Standard RAVLT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard RAVLT administration (true recognition + primacy recognition)
Trial: 11817496
Drug: Anticraving drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticraving drug expectancy
Trial: 7554698
Drug: Chloroguanide (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroguanide (200 mg orally)
Trial: 7554698
Drug: Chloroguanide with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroguanide with omeprazole (40 mg/day for 7 days)
Trial: 7554698
Drug: Mephenytoin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mephenytoin (100 mg orally)
Trial: 2202384
Drug: Zabicipril 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zabicipril 2.5 mg
Trial: 2202384
Drug: Zabicipril (0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zabicipril (0.03 to 10 mg)
Trial: 22828124
Drug: saxagliptin 2.5
RxNorm normalized name: sAXagliptin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: saxagliptin 2.5 mg q.A.M.
Trial: 22828124
Drug: saxagliptin 5
RxNorm normalized name: sAXagliptin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: saxagliptin 5 mg q.A.M.
Trial: 22828124
Drug: saxagliptin 5
RxNorm normalized name: sAXagliptin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: saxagliptin 5 mg q.P.M.
Trial: 22828124
Drug: saxagliptin (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: saxagliptin (all doses)
Trial: 20980999
Drug: Pazopanib 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pazopanib 800 mg with high-fat meal
Trial: 20980999
Drug: Pazopanib 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pazopanib 800 mg with low-fat meal
Trial: 20980999
Drug: Pazopanib 400
RxNorm normalized name: PAZOPanib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pazopanib 400 mg with high-fat meal
Trial: 11952027
Drug: Emedastine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emedastine plus placebo capsules
Trial: 11952027
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of emedastine and loratadine
Trial: 10551714
Drug: Propionyl-L-carnitine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propionyl-L-carnitine (1 g bid, p.o.)
Trial: 8635265
Drug: TAK-044 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAK-044 (10 to 1000 mg IV over a 15-minute period)
Trial: 8635265
Drug: TAK-044 (30,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAK-044 (30, 250, and 750 mg IV)
Trial: 8635265
Drug: TAK-044 (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAK-044 (1000 mg)
Trial: 1947791
Drug: Cimetidine 400
RxNorm normalized name: cimetidine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 400 mg three times daily for 6 days
Trial: 1947791
Drug: Placebo three
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo three times daily for 6 days
Trial: 6339137
Drug: Chymopapain injection
RxNorm normalized name: Chymopapain
DrugBank: Chymopapain (DB06752)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chymopapain injection (4000 IU, 2 ml)
Trial: 21316537
Drug: Voriconazole (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voriconazole (200 mg BID orally after a loading dose of 400 mg BID on day 1)
Trial: 21316537
Drug: Itraconazole (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole (100 mg BID orally, no loading dose)
Trial: 18553458
Drug: R1626 500
RxNorm normalized name: R1626
DrugBank: R1626 (DB05060)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R1626 500 mg
Trial: 18553458
Drug: R1626 1500
RxNorm normalized name: R1626
DrugBank: R1626 (DB05060)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R1626 1500 mg
Trial: 18553458
Drug: R1626 3000
RxNorm normalized name: R1626
DrugBank: R1626 (DB05060)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R1626 3000 mg
Trial: 18553458
Drug: R1626 4500
RxNorm normalized name: R1626
DrugBank: R1626 (DB05060)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R1626 4500 mg
Trial: 16491958
Drug: SCDSF treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCDSF treatment
Trial: 10811079
Drug: Vigabatrin monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vigabatrin monotherapy
Trial: 10811079
Drug: Carbamazepine monotherapy
RxNorm normalized name: Carbamazepine
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbamazepine monotherapy
Trial: 6360703
Drug: Inhalation powder
RxNorm normalized name: Inhalation Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation powder (1 mg fenoterol, 5 doses of 0.2 mg over 10 minutes)
Trial: 6360703
Drug: Pressurized aerosol
RxNorm normalized name: tetracaine
DrugBank: Tetracaine (DB09085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pressurized aerosol (1 mg fenoterol, 5 doses of 0.2 mg over 10 minutes)
Trial: 30449623
Drug: Cisplatin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (100 mg/m2 on days 1, 22, and 43 of radiotherapy)
Trial: 30449623
Drug: Cetuximab (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetuximab (400 mg/m2 loading dose followed by seven weekly infusions of 250 mg/m2)
Trial: 10599151
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone replacement therapy
Trial: 29959763
Drug: No recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No recombinant human growth hormone replacement therapy
Trial: 29959763
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment and cranial radiotherapy
Trial: 29959763
Drug: General treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General treatment outcomes
Trial: 26861603
Drug: Letrozole 2.5
RxNorm normalized name: letrozole 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole 2.5 mg daily for 5 years
Trial: 24402594
Drug: Mechanical bowel
RxNorm normalized name: ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mechanical bowel preparation (clear liquid diet and two self-administered saline enemas)
Trial: 21922153
Drug: Paclitaxel monotherapy
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel monotherapy (T)
Trial: 19116178
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin plus low-dose aspirin
Trial: 3011257
Drug: Etoposide (VP-16)
RxNorm normalized name: Etoposide
DrugBank: Etoposide (DB00773)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Etoposide (VP-16) at 300 mg/m2
Trial: 3011257
Drug: Etoposide (VP-16)
RxNorm normalized name: Etoposide
DrugBank: Etoposide (DB00773)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Etoposide (VP-16) at 600 mg/m2
Trial: 3011257
Drug: Etoposide (VP-16)
RxNorm normalized name: Etoposide
DrugBank: Etoposide (DB00773)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Etoposide (VP-16) at 900 mg/m2
Trial: 28864675
Drug: G-tube placement
RxNorm normalized name: Sus scrofa fallopian tube preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-tube placement
Trial: 25977146
Drug: Trimethoprim‐sulfamethoxazole 320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim‐sulfamethoxazole 320 mg/1600 mg twice daily
Trial: 25977146
Drug: Vancomycin 1
RxNorm normalized name: vancomycin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vancomycin 1 g twice daily
Trial: 16732143
Drug: One dose
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One dose of dexamethasone
Trial: 16732143
Drug: Three daily
RxNorm normalized name: bupropion
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Three daily doses of dexamethasone
Trial: 15465501
Drug: Tai chi
RxNorm normalized name: Ma Chi Xian
DrugBank: Purslane (DB14327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tai chi training (1‐hour class held twice weekly for 12 weeks)
Trial: 15465501
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care (pharmacologic therapy and dietary and exercise counseling)
Trial: 11394516
Drug: Lidocaine 5%
RxNorm normalized name: LIDOCAINE 5% OINT
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine 5% (100 mg in 7.5% glucose)
Trial: 11394516
Drug: Procaine 10%
RxNorm normalized name: procaine 10% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procaine 10% (100 mg diluted with 1 ml cerebrospinal fluid)
Trial: 9555823
Drug: 0.025% tretinoin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.025% tretinoin cream (commercially available)
Trial: 7672871
Drug: Amikacin (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amikacin (15 mg/kg per day) given in one (qd, n = 10) or two equal injections (b.i.d., n = 12) for durations of 7‐11 days
Trial: 7672871
Drug: Amikacin (qd
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amikacin (qd and b.i.d. administration)
Trial: 2646469
Drug: Intensified insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensified insulin therapy (IIT) with free mixtures of regular and intermediate (12 hrs)‐acting insulin
Trial: 2646469
Drug: Intensified insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensified insulin therapy (IIT) with basal and prandial insulin treatment (preprandial injections of regular insulin, and ultralente (24 hrs‐acting) or intermediate insulin for basal demand)
Trial: 25693010
Drug: Single-dose azithromycin
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Single-dose azithromycin
Trial: 26202150
Drug: Novel recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Novel recombinant human FSH (rhFSH, FE 999049) at doses of 5·2‐12·1 μg/day
Trial: 20028262
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg intravitreal ranibizumab (IVR) injection
Trial: 15105192
Drug: Metoprolol 10
RxNorm normalized name: metoprolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 10 mg
Trial: 15105192
Drug: Metoprolol 20
RxNorm normalized name: metoprolol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 20 mg
Trial: 15105192
Drug: Metoprolol 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 30 mg
Trial: 11368733
Drug: Salmeterol xinafoate,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol xinafoate, 42 microg twice per day (salmeterol‐minus group)
Trial: 11368733
Drug: Salmeterol xinafoate,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol xinafoate, 42 microg twice per day (salmeterol‐plus group)
Trial: 9038597
Drug: RRR-alpha-tocopherol and
RxNorm normalized name: RRR-alpha-tocopheryl acetate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RRR-alpha-tocopherol and RRR-alpha-tocopheryl acetate (administered in equal doses)
Trial: 8316388
Drug: Bier's block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bier's block with 0.6 mg of atropine in 10 ml of saline
Trial: 3555034
Drug: Ciprofloxacin 750
RxNorm normalized name: ciprofloxacin 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 750 mg orally every 12 hours (or 500 mg for the 13-year-old) for 2 to 8 weeks
Trial: 3555034
Drug: Tobramycin and
RxNorm normalized name: Tobramycin and Dexamethasone Ophthalmic Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tobramycin and azlocillin administered intravenously for at least two weeks
Trial: 26554670
Drug: Transcranial Direct
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcranial Direct Current Stimulation (tDCS) in addition to Tinnitus Retraining Therapy (TRT)
Trial: 26554670
Drug: Sham Transcranial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham Transcranial Direct Current Stimulation (tDCS) in addition to Tinnitus Retraining Therapy (TRT)
Trial: 23589371
Drug: Preladenant 5
RxNorm normalized name: Preladenant
DrugBank: Preladenant (DB11864)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preladenant 5 mg twice a day
Trial: 16921788
Drug: Oral estradiol
RxNorm normalized name: estradiol Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estradiol 2 mg/day for 12 weeks
Trial: 16921788
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol 50 microg/day (7-day patches) for 12 weeks
Trial: 16921788
Drug: Comparison between
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison between oral and transdermal therapy
Trial: 3669283
Drug: Cefuzonam (CZON)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuzonam (CZON) administered by intravenous injection or intravenous drip infusion, 1 g twice daily for 4 to 7 days (8 g to 14 g in total)
Trial: 26410046
Drug: Carotid endarterectomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carotid endarterectomy (CEA) with modern medical treatment (MMT)
Trial: 26410046
Drug: Modern medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modern medical treatment (MMT) alone
Trial: 21397567
Drug: Alemtuzumab (24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alemtuzumab (24 mg per day or 12 mg per day intravenously for 2 or 3 annual cycles)
Trial: 21397567
Drug: Interferon beta-1a
RxNorm normalized name: interferon beta-1a
DrugBank: Interferon beta-1a (DB00060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon beta-1a (44 μg subcutaneously three times per week)
Trial: 18347652
Drug: Protein-enriched recovery
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein-enriched recovery (0.7 g.kg(‐1).h(‐1) protein)
Trial: 18347652
Drug: Control recovery
RxNorm normalized name: Chem-Star Recover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control recovery (0.1 g.kg(‐1).h(‐1) protein)
Trial: 14728824
Drug: Anticoagulants therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticoagulants therapy
Trial: 10678121
Drug: Huperzine-A capsules
RxNorm normalized name: huperzine A
DrugBank: Huperzine A (DB04864)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Huperzine-A capsules (Hup) 50 micrograms, 2 capsules b.i.d. for 4 weeks
Trial: 10678121
Drug: Placebo (starch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (starch and lactose), 2 capsules b.i.d. for 4 weeks
Trial: 10678121
Drug: Huperzine-A capsules
RxNorm normalized name: huperzine A
DrugBank: Huperzine A (DB04864)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Huperzine-A capsules (Hup)
Trial: 1875406
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment groups (n = 25)
Trial: 6342360
Drug: Peer support
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peer support therapy group
Trial: 28150856
Drug: Cognitive behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioural therapy (CBT) in addition to pulmonary rehabilitation
Trial: 26714460
Drug: Lifestyle physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lifestyle physical activity - participants receive a resource pack and pedometer, aiming to increase daily steps to 10,000 steps/day.
Trial: 23988418
Drug: DBGT (double-brewed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DBGT (double-brewed green tea), 500 mL daily until recurrence or during a follow-up of 18 months
Trial: 31740428
Drug: GKT137831 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GKT137831 400 mg BID for 48 weeks
Trial: 23765950
Drug: Severe eosinophilia
RxNorm normalized name: acetaminophen / diphenhydramine hydrochloride Oral Tablet [Tylenol Severe Allergy]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Severe eosinophilia (≥ 1.0 × 10(9) /L)
Trial: 23765950
Drug: Mild eosinophilia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mild eosinophilia (≥ 0.5‐1.0 × 10(9) /L)
Trial: 9066005
Drug: Bradykinin infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bradykinin infusion
Trial: 8872666
Drug: Sodium nitroprusside
RxNorm normalized name: Sodium Nitroprusside
DrugBank: Nitroprusside (DB00325)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sodium nitroprusside infusion
Trial: 14733451
Drug: Intramuscular olanzapine
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular olanzapine (10.0 mg)
Trial: 10883158
Drug: Daily i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily i.v. glucosamine sulfate (GS) together with 800 mg chondroitin sulfate for 4 weeks
Trial: 8255520
Drug: Ganciclovir (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ganciclovir (5 mg/kg b.i.d./day for 14 days)
Trial: 3987531
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 mg, retard form)
Trial: 1995258
Drug: Verapamil (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (160 mg)
Trial: 22959318
Drug: 5% dextrose
RxNorm normalized name: LMD with 5% Dextrose
DrugBank: D-glucose (DB01914)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% dextrose in normal saline solution
Trial: 9360566
Drug: Premixed slurry
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Premixed slurry of deferoxamine mesylate (DFO) and activated charcoal (AC) with 5 mg/kg ferrous sulfate and 8 g of DFO and 25 g of 20% AC
Trial: 9360566
Drug: 5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/kg ferrous sulfate alone
Trial: 9360566
Drug: 5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/kg ferrous sulfate added to 25 g of 20% AC
Trial: 1492440
Drug: Conventional or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional or no antiarrhythmic therapy
Trial: 24513787
Drug: Interleukin‐2 receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interleukin‐2 receptor antagonists (daclizumab or basiliximab)
Trial: 23056520
Drug: Acidform gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acidform gel
Trial: 23056520
Drug: HEC placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HEC placebo gel
Trial: 1927911
Drug: nisoldipine 10
RxNorm normalized name: nisoldipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nisoldipine 10 mg once daily
Trial: 1927911
Drug: nisoldipine 10
RxNorm normalized name: nisoldipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nisoldipine 10 mg twice daily
Trial: 1927911
Drug: nisoldipine 20
RxNorm normalized name: nisoldipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nisoldipine 20 mg once daily
Trial: 29251433
Drug: Not feeling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Not feeling ready to seek treatment
Trial: 23343932
Drug: Pentavalent bovine‐human
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentavalent bovine‐human reassortant rotavirus vaccine
Trial: 19101754
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral 1 mg minodronate for 24 months
Trial: 15258682
Drug: Policosanol 10
RxNorm normalized name: policosanol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Policosanol 10 mg bid
Trial: 15258682
Drug: Ticlopidine 250
RxNorm normalized name: ticlopidine 250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine 250 mg bid
Trial: 11528141
Drug: Propranolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (40 mg twice a day, adjusted weekly until a minimum decrease of 20% in cardiac frequency achieved)
Trial: 9401836
Drug: Ketamine (2.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (2.5, 3.5, or 6.0 mg/kg) via jet injector
Trial: 9401836
Drug: Ketamine (dosage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (dosage based on mg/m2 body surface area or mg/kg body weight)
Trial: 8438810
Drug: DT-aP vaccine
RxNorm normalized name: AP-101
DrugBank: AP-101 (DB17947)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DT-aP vaccine
Trial: 8438810
Drug: WC-DTP vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WC-DTP vaccine
Trial: 2979214
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg o.m. for 14 days
Trial: 22717925
Drug: Drug-eluting stents
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-eluting stents (Cypher; Cordis, Miami Lakes, FL, USA; n=20 patients)
Trial: 20130836
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg morphine in 20 ml saline
Trial: 20130836
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml 0.25% bupivacaine
Trial: 20130836
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml saline (placebo)